Cadrenal Therapeutics Inc
NASDAQ:CVKD
Shareholder Yield
Current shareholder yield for CVKD is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CVKD Price
Cadrenal Therapeutics Inc
| Average Annual Return | 331 977.81% |
| Standard Deviation of Annual Returns | 469 408.86% |
| Max Drawdown | -92% |
| Market Capitalization | 11.5m USD |
| Shares Outstanding | 2 340 000 |
| Percentage of Shares Shorted | 3.17% |
CVKD Return Decomposition
Main factors of price return
Stock Splits
CVKD's latest stock split occurred on Aug 20, 2024
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, CVKD traded at 0.402 per share. Afterward, the share price was about 7.185.
The adjusted shares began trading on Aug 20, 2024. This was the only stock split in CVKD's history.
